Conquer
Conquer, licence 80051610: inactive licence in Health Canada data. The French and European references below do not constitute authorisation for sale in France or an assessment of safety or efficacy.
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
Natural health product licensed in Canada
- Licence holder
- Tribravus Enterprises, LLC. dba IFORCE Nutrition
- NPN or DIN-HM
- 80051610
- Status
- Inactive licence
- Licence date
- 10 June 2014
- Revision date
- 17 June 2014
- Form
- Poudre
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
- Conditions légales
Contains tea (Camellia sinensis). Green tea extracts must provide less than 800 mg of epigallocatechin-3-gallate per daily portion, with mandatory warnings.
annexe III, partie B (règlement (UE) 2022/2340). Regulation (EC) No 1925/2006, latest consolidated version, retrieved 21 October 2026.
- Conditions légales
Camellia sinensis (L.) Kuntze: Seules sont admises la poudre issue du broyage des feuilles et les préparations obtenues à partir des solvants suivants : l'eau, l'alcool à 25 % (v/v), ainsi que les solvants autorisés pour la décaféination ou la suppression des matières irritantes et amères. Les recommandations d'emploi ne doivent pas conduire à une ingestion quotidienne d'EGCG supérieure à 300 mg. L'étiquetage doit comporter des avertissements déconseillant leur prise en dehors des repas, ainsi que leur consommation par les enfants, les adolescents, les femmes enceintes ou allaitantes.
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
- Conditions légales
Citrus aurantium L.: La quantité ingérée de p-synéphrine doit être inférieure à 20 mg par dose journalière recommandée. L'étiquetage doit comporter un avertissement déconseillant l'emploi aux enfants, aux femmes enceintes ou allaitantes et en cas de traitement anti-hypertenseur. La caféine et les sources de caféine ne sont pas autorisées dans les compléments alimentaires contenant Citrus aurantium L.
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| 2-para-Hydroxyphenylethylamine Source : Citrus sinensis - fruit | 75.0 mg | Not calculated |
| 1,3,7-Triméthylxanthine Source : Caféine | 93.75 mg | Not calculated |
| Acide 2-aminoéthanesulfonique Source : Taurine | 1125.0 mg | Not calculated |
| Phosphore Source : Phosphate de potassium dibasique | 5.788 mg | Not calculated |
| Phosphore Source : Phosphate de sodium dibasique | 5.788 mg | Not calculated |
| Niacine Source : Niacine | 12.5 mg | Not calculated |
| Potassium Source : Acétate de potassium | 3.66 mg | Not calculated |
| Camellia sinensis Source : Feuille Extraction ratio : 100:1 Dry plant equivalent : 3800 mg | 38.0 mg | Not calculated |
| Citrus aurantium Source : Fruit Extraction ratio : 20:1 Dry plant equivalent : 750 mg Potency : 30.0 % Synephrine | 37.5 mg | Not calculated |
| N-(Aminoiminométhyl)-N-méthylglycine monohydraté Source : Créatine monohydratée | 1724.0 mg | Not calculated |
| Magnésium Source : Phosphate de magnésium, tribasique tétrahydraté | 2.5 mg | Not calculated |
| Sodium Source : Lactate de sodium | 2.4 mg | Not calculated |
| Vitamine B12 Source : Méthylcobalamine | 125.0 mcg | Not calculated |
Non-medicinal ingredients
Acesulfame-K, L-leucine, Dioxyde de silicium, Acid citrique, Saveur, Sucralose
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | 1.0 Mesures | 1.0 Tous les jours |
Uses authorised in Canada
Text supplied in English because no French text is available.
Helps temporarily to relieve fatigue, promote endurance and enhance motor performance. Helps to promote alertness and wakefulness and to enhance cognitive performance.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Warnings are available in English on the official record.
Source
Official Health Canada record, licence 80051610
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).
List recorded in 2014. Photograph the packaging to check whether it has changed.
Has the product changed? Photograph the packaging.